MALAISE is the #9 most commonly reported adverse reaction for INFLIXIMAB DYYB, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 2,844 FDA adverse event reports linking INFLIXIMAB DYYB to MALAISE. This represents approximately 2.0% of all 142,758 adverse event reports for this drug.
Patients taking INFLIXIMAB DYYB who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
MALAISE2,844 of 142,758 reports
MALAISE is a less commonly reported adverse event for INFLIXIMAB DYYB, but still significant enough to appear in the safety profile.
Other Side Effects of INFLIXIMAB DYYB
In addition to malaise, the following adverse reactions have been reported for INFLIXIMAB DYYB:
MALAISE has been reported as an adverse event in 2,844 FDA reports for INFLIXIMAB DYYB. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is MALAISE with INFLIXIMAB DYYB?
MALAISE accounts for approximately 2.0% of all adverse event reports for INFLIXIMAB DYYB, making it a notable side effect.
What should I do if I experience MALAISE while taking INFLIXIMAB DYYB?
If you experience malaise while taking INFLIXIMAB DYYB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.